Double TOF

Foster City, Calif.-based Applied Biosystems (ABI) officially launched its entry into the proteomics market, the 4700 Proteomics Analyzer, in January. Based on the first commercially available, tandem time-of-flight (TOF/TOF™) mass spectrometer (MS) and offering a number of productivity-enhancing features, the 4700 is designed specifically to excel at proteomics applications, according to David Hicks, ABI's director of marketing for proteomics applications. The 4700 includes the matrix-a

Written byJeffrey Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The 4700 includes the matrix-assisted laser desorption/ionization (MALDI)-TOF/TOF instrument, a computer, an embedded Oracle database, and instrument control and data analysis software. Optional accessories include a 24-plate autoloader, which allows the instrument to handle nearly 1,200 samples per hour in an unattended run, a 16-tip robotic spotter, and proteomics-specific application software.

According to Hicks, the 4700's TOF/TOF configuration provides "the high resolution, high sensitivity, and high mass accuracy that TOF-based instruments give you, combined with true MS/MS capability." This tandem MS capability allows researchers to select a specific peptide ion in the first TOF MS, fragment it by collision-induced dissociation, and obtain peptide sequence data in the second MS. But unlike other tandem configurations, such as the more common quadrupole-TOF, the 4700 uses high-energy fragmentation, which generates additional molecular information such as the difference between leucine and isoleucine side chains.

ABI made several enhancements to improve the system's throughput. Whereas ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies